ASX Penny Stock Highlights: Alligator Energy Among 3 Notable Picks

In This Article:

The ASX200 is poised to open higher, reflecting Wall Street's positive momentum driven by a strong jobs report and easing trade tensions. While the term 'penny stock' might seem outdated, it still represents an intriguing investment area where smaller or newer companies can offer substantial opportunities. By focusing on those with robust financials and potential for growth, investors may uncover hidden gems within the market's lesser-known segments.

Top 10 Penny Stocks In Australia

Name

Share Price

Market Cap

Financial Health Rating

CTI Logistics (ASX:CLX)

A$1.695

A$136.52M

★★★★☆☆

Accent Group (ASX:AX1)

A$1.885

A$1.07B

★★★★☆☆

EZZ Life Science Holdings (ASX:EZZ)

A$1.405

A$66.28M

★★★★★★

IVE Group (ASX:IGL)

A$2.62

A$403.96M

★★★★★☆

GTN (ASX:GTN)

A$0.60

A$115.38M

★★★★★★

West African Resources (ASX:WAF)

A$2.32

A$2.64B

★★★★★★

Bisalloy Steel Group (ASX:BIS)

A$3.30

A$156.59M

★★★★★★

Regal Partners (ASX:RPL)

A$2.06

A$692.5M

★★★★★★

Navigator Global Investments (ASX:NGI)

A$1.65

A$808.63M

★★★★★☆

NRW Holdings (ASX:NWH)

A$2.73

A$1.25B

★★★★★☆

Click here to see the full list of 988 stocks from our ASX Penny Stocks screener.

Underneath we present a selection of stocks filtered out by our screen.

Alligator Energy

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Alligator Energy Limited is involved in mineral exploration activities in Australia and Italy, with a market cap of A$120.10 million.

Operations: Alligator Energy Limited does not currently report any revenue segments.

Market Cap: A$120.1M

Alligator Energy, with a market cap of A$120.10 million, is currently pre-revenue and unprofitable, reporting losses of A$1.47 million for the half year ended December 2024. The company's financial stability is supported by short-term assets of A$21.1 million outweighing liabilities and a cash runway exceeding one year without debt reliance. Recent challenges include halted drilling at the Big Lake Uranium Project due to flooding in South Australia, impacting exploration timelines. Despite these setbacks, management's extensive experience may offer strategic resilience as earnings are forecasted to grow significantly annually despite current volatility in share price movements.

ASX:AGE Financial Position Analysis as at May 2025
ASX:AGE Financial Position Analysis as at May 2025

Biome Australia

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Biome Australia Limited focuses on the development, commercialization, and marketing of live biotherapeutics and complementary medicines both in Australia and internationally, with a market cap of A$108.56 million.